39 Because CaMKII is elevated in diabetes,40 SGLT-2i use may directly reduce Ca2+ release and the risk of arrhythmias and SCA in patients with type 2 diabetes. The gene discussed is CAMK2G; the disease is type 2 diabetes mellitus.